Testing effectiveness (Phase 2)Study completedNCT04159805What this trial is testingTAK-079 in People With Generalized Myasthenia GravisWho this might be right forMyasthenia Gravis Takeda 36
Post-approval studies (Phase 4)Study completedNCT00987116What this trial is testingStudy Comparing Two Tapering Strategies of Prednisone in Myasthenia GravisWho this might be right forMyasthenia Gravis Assistance Publique - Hôpitaux de Paris 118
Large-scale testing (Phase 3)Active Not RecruitingNCT05070858What this trial is testingTest How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia GravisWho this might be right forGeneralized Myasthenia Gravis Regeneron Pharmaceuticals 288
Early research (Phase 1)Not Yet RecruitingNCT07714798What this trial is testingUniversal STAR-T Cell Injection in Generalized Myasthenia GravisWho this might be right forGeneralized Myasthenia Gravis Daishi Tian 10
Not applicableLooking for participantsNCT06617741What this trial is testingMyasthenia Gravis Foundation of America Global MG Patient RegistryWho this might be right forMyasthaenia GravisMyastheniaMyasthenia Gravis Associated with Thymoma+10 more Myasthenia Gravis Foundation of America 3,800
Not applicableLooking for participantsNCT04202341What this trial is testingRegistry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)Who this might be right forGeneralized Myasthenia Gravis Alexion Pharmaceuticals, Inc. 500
Not applicableLooking for participantsNCT07247279What this trial is testingEpidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in RussiaWho this might be right forRare DiseasesGeneralized Myasthenia Gravis (gMG) AstraZeneca 450
Large-scale testing (Phase 3)Looking for participantsNCT04833894What this trial is testingEvaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia GravisWho this might be right forGeneralized Myasthenia Gravis argenx 12
Large-scale testing (Phase 3)Study completedNCT06764160What this trial is testingEfficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMGWho this might be right forGeneralized Myasthenia Gravis (gMG)Refractory gMG Alexion Pharmaceuticals, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT02565576What this trial is testingSafety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia GravisWho this might be right forMyasthenia Gravis, Generalized Novartis Pharmaceuticals 44
Not applicableStudy completedNCT02066519What this trial is testingBenefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia GravisWho this might be right forMyasthenia Gravis Assistance Publique - Hôpitaux de Paris 45
Large-scale testing (Phase 3)Study completedNCT05681715What this trial is testingA Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)Who this might be right forGeneralized Myasthenia Gravis UCB Biopharma SRL 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT06704269What this trial is testingStudy to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia GravisWho this might be right forGeneralized Myasthenia Gravis Novartis Pharmaceuticals 15
Testing effectiveness (Phase 2)Ended earlyNCT03896295What this trial is testingAn Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia GravisWho this might be right forGeneralized Myasthenia Gravis Momenta Pharmaceuticals, Inc. 37
Not applicableUnknownNCT05214612What this trial is testingPredictors and Prognostic Factors of Myasthenia Gravis OutcomeWho this might be right forMyasthenia GravisAutoimmune Diseases of the Nervous SystemNeuromuscular Junction Diseases+9 more Assiut University 30
Large-scale testing (Phase 3)Study completedNCT03304054What this trial is testingStudy to Evaluate Amifampridine Phosphate in Patients With MuSK-MGWho this might be right forMyasthenia Gravis, Generalized Catalyst Pharmaceuticals, Inc. 93
Not applicableNot Yet RecruitingNCT07677852What this trial is testingSexual and Urinary Dysfunctions in Generalized MyastheniaWho this might be right forMyasthenia Gravis (MG) Centre Hospitalier Universitaire de Nice 150
Early research (Phase 1)Looking for participantsNCT06688435What this trial is testingEvaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia GravisWho this might be right forMyasthenia Gravis CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 60
Post-approval studies (Phase 4)Looking for participantsNCT06909214What this trial is testingEvaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)Who this might be right forNew Onset Generalized Myasthenia Gravis (gMG) argenx 30
Large-scale testing (Phase 3)Study completedNCT03920293What this trial is testingSafety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia GravisWho this might be right forGeneralized Myasthenia Gravis Alexion Pharmaceuticals, Inc. 175